Navigation Links
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Date:11/5/2009

ffected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
6. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. Medarex to Receive Milestone Payment from Amgen
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... The controversy surrounding the use of ... (procedures to remove uterine fibroids) continues, as a ... Johnson & Johnson,s Ethicon, Inc. unit, which was ... to the report published by The Wall Street ... is trying to determine what the company knew ...
(Date:5/28/2015)... 2015 Research and Markets ... the "United States Medical Adhesives Market Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , ... the United States is projected to ... Medical device manufacturers across the US are expanding ...
(Date:5/28/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces ... June 4 at 1:00 p.m. ET / 10:00 a.m. ... Internet.  Simply log onto our website listed above. If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting its leadership ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... MedPro Imaging, a premium provider ... the expansion of its operations with the opening ... in Longmont, Colo.  The 5,000-square foot facility features ... U.S. market, offering high quality computer-based transducer repair ...
... Botanic Pharmaceutical Inc. (NYSE AMEX: CBP ) ... distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ... successfully completed a feasibility study to analyze the benefits ... production operations. As a result of the study, the ...
Cached Medicine Technology:MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 2MedPro Imaging Expands Operations With Opening of Dedicated Advanced Transducer Repair Facility 3China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 2China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets 3
(Date:5/29/2015)... 29, 2015 Healthpointe is excited to ... Therapy (JFT) at their clinics in Orange County. The ... that assists in diminishing pain for patients with osteoarthritis, ... Katz and Dr. Neil Katz of Healthpointe. Supartz is ... (also known as hyaluronic acid) a natural substance found ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report on H1 2015 pipeline ... data tables and 13 figures, spread across ...
(Date:5/29/2015)... Health DataPalooza is a national conference that ... foster the most effective and innovative ways to use ... hosted by the Health Data Consortium, which is a ... and develop the use of open healthcare data. ... narrow in on how to actually put the ideas ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Recently, ... presented on longevity in facelift surgery before the 46th ... Puerto Vallarta, Mexico. In his presentation, Dr. Rohrich, a ... Distinguished Teaching Professor of Plastic Surgery at UT Southwestern ... to facial rejuvenation as they relate to obtaining long ...
(Date:5/29/2015)... 2015 The world of dentistry had an ... dentists as sadists who dispense pain to people unfortunate enough ... more, when it came to surgeries, people would have to ... but that's all back in the 20th Century now. Nowadays ... in the Sheepshead Bay neighborhood of Brooklyn, New ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 2Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4
... University psychologist clearly identifies the parts of the brain ... speech. , The study, published in the current issue ... Sciences , could help researchers better understand the speech ... person must select one word from a competing set ...
... , ... (PRWEB) December 24, 2008 -- Having decided to help support ... to find The House of Good Health in Senga Bay, Malawi. ... to manage their disease by providing financial, nutritional, and emotional support. Nick ...
... deal? Think again. , ... Phoenix, AZ (Vocus) December 23, 2008 -- ... exercise more, study results released in the December 23rd issue of Circulation ... day. Challenged by sedentary job structures most Americans fall far short of ...
... cost of prescription drugs and save money elsewhere in ... by researchers at the University of Illinois at Chicago. ... systems to provide clinical pharmacy services, $4.81 was saved ... and medication errors and other savings, says Glen Schumock, ...
... better product and so it also seems to go ... genes rearrange to allow antibodies to recognize different foreign ... recognize and attack the body,s own cells. These ... be edited into versions that won,t attack self. This ...
... Mast cells are now recognized as "granular cells of ... and as key players in the establishment of innate ... The role of mast cells in the gastrointestinal mucosa ... to actively regulate the barrier and transport properties of ...
Cached Medicine News:Health News:Rice psychologist identifies area of brain key to choosing words 2Health News:The Web Project visits The House of Good Health in Malawi 2Health News:Treadmill Desks to the Rescue: Weight Control and Activity Critical in Preventing Heart Failure 2Health News:Reduction in antibody gene rearrangement in B cells related to type 1 diabetes, lupus 2Health News:What is the effect of fluoxetine on mast cell? 2
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
The Model 305 is a hand-held, portable, lightweight oximeter designed for spot checking. It has a NiCad rechargeable battery....
... memory capabilities for overnight sleep screening., ,The ... and pulse rate data, and can operate in ... ,1. The Model 130 can retain up ... patient, making the device ideally suited for treadmill ...
Medicine Products: